Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2018-10-22 2018-10-22
Drug Identification Number 02304317 02304317
Brand name ACT VENLAFAXINE XR ACT VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR VENLAFAXINE XR
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients VENLAFAXINE VENLAFAXINE
Strength(s) 37.5MG 37.5MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-06-30 2018-06-30
Remaining supply date 2018-09-30 2018-09-30
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments